HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valacyclovir in the treatment of acute retinal necrosis.

AbstractBACKGROUND:
To report the outcome of oral valacyclovir as the sole antiviral therapy for patients with acute retinal necrosis (ARN).
METHODS:
This study reports a retrospective, interventional case series of nine consecutive patients with ten eyes with newly diagnosed ARN treated with oral valacyclovir as the sole antiviral agent. Eight patients received oral valacyclovir 2 g tid (Valtrex, GlaxoSmithKline) and one patient with impaired renal function received oral 1 g tid. The main outcome measures were response to treatment, time to initial response to treatment, time to complete resolution of retinitis, best corrected visual acuity (BCVA) at final follow-up, retinal detachment and development of recurrent or second eye disease.
RESULTS:
Retinitis resolved in ten of ten (100%) affected eyes. The median time to initial detectable response was seven days and the median time to complete resolution was 21 days. A final BCVA of 20/40 or better was achieved in 6/10 (60%) of eyes. 3/10 eyes (30%) developed a retinal detachment. No patients developed either disease reactivation or second eye involvement over the course of the study (mean follow up 31 weeks, range 7 to 104 weeks).
CONCLUSIONS:
Treatment with oral valacyclovir as the sole antiviral therapy resulted in complete resolution of retinitis. Final BCVA and retinal detachment rate were comparable with previously reported outcomes for intravenous acyclovir.
AuthorsSimon Rj Taylor, Robin Hamilton, Claire Y Hooper, Lavnish Joshi, Jiten Morarji, Nitin Gupta, Sue L Lightman
JournalBMC ophthalmology (BMC Ophthalmol) Vol. 12 Pg. 48 (Sep 05 2012) ISSN: 1471-2415 [Electronic] England
PMID22947428 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Prodrugs
  • Valine
  • Valacyclovir
  • Acyclovir
Topics
  • Acyclovir (administration & dosage, analogs & derivatives)
  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents (administration & dosage)
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prodrugs
  • Retinal Necrosis Syndrome, Acute (diagnosis, drug therapy)
  • Retrospective Studies
  • Treatment Outcome
  • Valacyclovir
  • Valine (administration & dosage, analogs & derivatives)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: